|
1
|
Game X, Soulie M, Moussouni S, Roux D,
Escourrou G, Chevreau C and Aziza R: Renal angiomyolipoma
associated with rapid enlargement and inferior vena caval tumor
thrombus. J Urol. 170:918–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hassan M, El-Hefnawy AS, Elshal AM, Mosbah
A, El-Baz M and Shaaban A: Renal epithelioid angiomyolipoma: A rare
variant with unusual behavior. Int Urol Nephrol. 46:317–322. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moch H, Humphrey PA, Ulbright TM and
Reuter VE: WHO classification of tumours of the urinary system and
male genital organs. (4th). IARC Press. (Lyon). 2016.
|
|
4
|
Lane BR, Aydin H, Danforth TL, Zhou M,
Remer EM, Novick AC and Campbell SC: Clinical correlates of renal
angiomyolipoma subtypes in 209 patients: Classic, fat poor,
tuberous sclerosis associated and epithelioid. J Urol. 180:836–843.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He W, Cheville JC, Sadow PM, Gopalan A,
Fine SW, Al-Ahmadie HA, Chen YB, Oliva E, Russo P, Reuter VE, et
al: Epithelioid angiomyolipoma of the kidney: Pathological features
and clinical outcome in a series of consecutively resected tumors.
Mod Pathol. 26:1355–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aydin H, Magi-Galluzzi C, Lane BR, Sercia
L, Lopez JI, Rini BI and Zhou M: Renal angiomyolipoma:
Clinicopathologic study of 194 cases with emphasis on the
epithelioid histology and tuberous sclerosis association. Am J Surg
Pathol. 33:289–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brimo F, Robinson B, Guo C, Zhou M, Latour
M and Epstein JI: Renal epithelioid angiomyolipoma with atypia: A
series of 40 cases with emphasis on clinicopathologic prognostic
indicators of malignancy. Am J Surg Pathol. 34:715–722.
2010.PubMed/NCBI
|
|
8
|
Nese N, Martignoni G, Fletcher CD, Gupta
R, Pan CC, Kim H, Ro JY, Hwang IS, Sato K, Bonetti F, et al: Pure
epithelioid PEComas (so-called epithelioid angiomyolipoma) of the
kidney: A clinicopathologic study of 41 cases: detailed assessment
of morphology and risk stratification. Am J Surg Pathol.
35:161–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei JH, Liu LR, Wei Q, Song TR, Yang L,
Yuan HC, Jiang Y, Xu H, Xiong SH and Han P: A four-year follow-up
study of renal epithelioid angiomyolipoma: A multi-center
experience and literature review. Sci Rep. 5:100302015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sancak O, Nellist M, Goedbloed M,
Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S,
Halley D and van den Ouweland A: Mutational analysis of the TSC1
and TSC2 genes in a diagnostic setting: Genotype - phenotype
correlations and comparison of diagnostic DNA techniques in
Tuberous Sclerosis Complex. Eur J Hum Genet. 13:731–741. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crino PB, Nathanson KL and Henske EP: The
tuberous sclerosis complex. N Engl J Med. 355:1345–1356. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bissler JJ and Kingswood JC: Optimal
treatment of tuberous sclerosis complex associated renal
angiomyolipomata: A systematic review. Ther Adv Urol. 8:279–290.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Henske EP, Neumann HP, Scheithauer BW,
Herbst EW, Short MP and Kwiatkowski DJ: Loss of heterozygosity in
the tuberous sclerosis (TSC2) region of chromosome band 16p13
occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Genes Chromosomes Cancer. 13:295–298. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chuang CK, Lin HCA, Tasi HY, Lee KH, Kao
Y, Chuang FL, Chang YH, Lin PH, Liu CY and Pang ST: Clinical
presentations and molecular studies of invasive renal epithelioid
angiomyolipoma. Int Urol Nephrol. 49:1527–1536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kenerson H, Folpe AL, Takayama TK and
Yeung RS: Activation of the mTOR pathway in sporadic
angiomyolipomas and other perivascular epithelioid cell neoplasms.
Hum Pathol. 38:1361–1371. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bissler JJ and Kingswood JC: Renal
angiomyolipomata. Kidney Int. 66:924–934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mai KT, Perkins DG and Collins JP:
Epithelioid cell variant of renal angiomyolipoma. Histopathology.
28:277–280. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martignoni G, Pea M, Bonetti F, Zamboni G,
Carbonara C, Longa L, Zancanaro C, Maran M, Brisigotti M and
Mariuzzi GM: Carcinomalike monotypic epithelioid angiomyolipoma in
patients without evidence of tuberous sclerosis: A
clinicopathologic and genetic study. Am J Surg Pathol. 22:663–672.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi N, Kitahara R, Hishimoto Y,
Ohguro A, Hashimoto Y and Suzuki T: Malignant transformation of
renal angiomyolipoma. Int J Urol. 10:271–273. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bi XG, Guo L, Wang XL, Wei Q, Du Q, Jiang
WH, Zheng GY, Zhang HT, Ma JH and Zheng S: Distinct subcellular
localization of E-cadherin between epithelioid angiomyolipoma and
triphasic angiomyolipoma: A preliminary case-control study. Oncol
Lett. 14:695–704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caliò A, Brunelli M, Segala D, Pedron S,
Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, et
al: t(6;11) renal cell carcinoma: A study of seven cases including
two with aggressive behavior, and utility of CD68 (PG-M1) in the
differential diagnosis with pure epithelioid PEComa/epithelioid
angiomyolipoma. Mod Pathol. 31:474–487. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gulavita P, Fletcher CDM and Hirsch MS:
PNL2: An adjunctive biomarker for renal angiomyolipomas and
perivascular epithelioid cell tumours. Histopathology. 72:441–448.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng S, Bi XG, Song QK, Yuan Z, Guo L,
Zhang H and Ma JH: A suggestion for pathological grossing and
reporting based on prognostic indicators of malignancies from a
pooled analysis of renal epithelioid angiomyolipoma. Int Urol
Nephrol. 47:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamakado K, Tanaka N, Nakagawa T,
Kobayashi S, Yanagawa M and Takeda K: Renal angiomyolipoma:
Relationships between tumor size, aneurysm formation, and rupture.
Radiology. 225:78–82. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schieda N, Kielar AZ, Al Dandan O, McInnes
MD and Flood TA: Ten uncommon and unusual variants of renal
angiomyolipoma (AML): Radiologic-pathologic correlation. Clin
Radiol. 70:206–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Froemming AT, Boland J, Cheville J,
Takahashi N and Kawashima A: Renal epithelioid angiomyolipoma:
Imaging characteristics in nine cases with radiologic-pathologic
correlation and review of the literature. AJR Am J Roentgenol.
200:W178–W186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong Y, Shen Y, Pan J, Wang Y, An Y, Guo
A, Ma L, Ye H and Wang H: Renal epithelioid angiomyolipoma: MRI
findings. Radiol Med (Torino). 122:814–821. 2017. View Article : Google Scholar
|
|
28
|
Nelson CP and Sanda MG: Contemporary
diagnosis and management of renal angiomyolipoma. J Urol.
168:1315–1325. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ouzaid I, Autorino R, Fatica R, Herts BR,
McLennan G, Remer EM and Haber GP: Active surveillance for renal
angiomyolipoma: Outcomes and factors predictive of delayed
intervention. BJU Int. 114:412–417. 2014.PubMed/NCBI
|
|
30
|
Vicens RA, Jensen CT, Korivi BR and
Bhosale PR: Malignant renal epithelioid angiomyolipoma with liver
metastasis after resection: A case report with multimodality
imaging and review of the literature. J Comput Assist Tomogr.
38:574–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cibas ES, Goss GA, Kulke MH, Demetri GD
and Fletcher CD: Malignant epithelioid angiomyolipoma (‘sarcoma ex
angiomyolipoma’) of the kidney: A case report and review of the
literature. Am J Surg Pathol. 25:121–126. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ferry JA, Malt RA and Young RH: Renal
angiomyolipoma with sarcomatous transformation and pulmonary
metastases. Am J Surg Pathol. 15:1083–1088. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lowe BA, Brewer J, Houghton DC, Jacobson E
and Pitre T: Malignant transformation of angiomyolipoma. J Urol.
147:1356–1358. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
El-Hashemite N, Zhang H, Henske EP and
Kwiatkowski DJ: Mutation in TSC2 and activation of mammalian target
of rapamycin signalling pathway in renal angiomyolipoma. Lancet.
361:1348–1349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng ZF, Yang L, Wang TT, Han P, Liu ZH
and Wei Q: Efficacy and safety of sirolimus for renal
angiomyolipoma in patients with tuberous sclerosis complex or
sporadic lymphangioleiomyomatosis: A systematic review. J Urol.
192:1424–1430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kohno J, Matsui Y, Yamasaki T, Shibasaki
N, Kamba T, Yoshimura K, Sumiyoshi S, Mikami Y and Ogawa O: Role of
mammalian target of rapamycin inhibitor in the treatment of
metastatic epithelioid angiomyolipoma: A case report. Int J Urol.
20:938–941. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shitara K, Yatabe Y, Mizota A, Sano T,
Nimura Y and Muro K: Dramatic tumor response to everolimus for
malignant epithelioid angiomyolipoma. Jpn J Clin Oncol. 41:814–816.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wolff N, Kabbani W, Bradley T, Raj G,
Watumull L and Brugarolas J: Sirolimus and temsirolimus for
epithelioid angiomyolipoma. J Clin Oncol. 28:e65–e68. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wagner AJ, Malinowska-Kolodziej I, Morgan
JA, Qin W, Fletcher CD, Vena N, Ligon AH, Antonescu CR, Ramaiya NH,
Demetri GD, et al: Clinical activity of mTOR inhibition with
sirolimus in malignant perivascular epithelioid cell tumors:
Targeting the pathogenic activation of mTORC1 in tumors. J Clin
Oncol. 28:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
